Please wait while the formulary information is being retrieved.
CYSTAGON (CYSTEAMINE BITARTRATE)
- Cystinosis
150 mg capsule
- 3 capsules (450 mg) with 1 x 50 mg capsule (50 mg) by oral route4 times per day
50 mg capsule
- 1 capsule (50 mg) with 3 x 150 mg capsules (450 mg) by oral route 4 times per day
Cystinosis
- 1 capsule (50 mg) with 3 x 150 mg capsules (450 mg) by oral route 4 times per day
- 3 capsules (450 mg) with 1 x 50 mg capsule (50 mg) by oral route4 times per day
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- Pregnancy
Severe
Moderate
- Depression
- Disease of liver
- Fracture
- Gastrointestinal hemorrhage
- Gastrointestinal ulcer
- Idiopathic intracranial hypertension
- Leukopenia
- Osteopenia
- Seizure disorder
CYSTAGON (CYSTEAMINE BITARTRATE)
- Cystinosis
- Dehydration
- Diarrhea
- Fever
- Gastroenteritis
- Headache disorder
- Influenza
- Lethargy
- Nausea
- Skin rash
- Vomiting
- Acute abdominal pain
- Anorexia
- Arthralgias
- Body odor
- Conjunctivitis
- Cough
- Fatigue
- Halitosis
- Infection of ear
- Limb pain
- Pharyngitis
- Upper respiratory infection
More Frequent
Severe
Less Severe
- Acute confusion
- Depression
- Dizziness
- Sore throat
- Tremor
- Constipation
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Acquired genu valgum
- Anemia
- Compression fracture
- Erythema multiforme
- Gastrointestinal hemorrhage
- Gastrointestinal ulcer
- Hyperextension of joint
- Hypertension
- Hypocalcemia
- Hypokalemia
- Hypovolemia
- Idiopathic intracranial hypertension
- Leukopenia
- Ocular pain
- Osteopenia
- Papilledema
- Scoliosis
- Seizure disorder
- Skin lesion
- Skin striae
- Stevens-johnson syndrome
- Toxic epidermal necrolysis
Less Severe
- Drowsy
- Leg pain
- Skin atrophy
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Cysteamine(oral)
- Severity Level:
D
- Additional Notes: Insuff human data avail; teratogenic animals at 0.2-0.7 times the mrhd
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Cysteamine
Insufficient data available
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Cystinosis | |
| E72.04 | Cystinosis |
| 0-9 | A-Z |
|---|---|
| E72.04 | Cystinosis |
Formulary Reference Tool